MedTrace Logo

Levels of 'Hypophosphatemia Affect Outcome of Septic Patients in ICU

NCT04519762 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-08-20

No results posted yet for this study

Summary

The current study aimed to determine the incidence of hypophosphatemia (HP) among severe sepsis/septic shock patients admitted to ICU and its impact on morbidity and mortality rates of these patients, and to evaluate the impact of phosphorous supplemental therapy (PST) on such outcomes.Thus, this study will hypothesize that diagnosis and management of HP may be advantageous for reduction of morbidity and mortality rates of septic patients admitted to ICU.

Conditions

  • Hypophosphatemia

Interventions

DRUG

Glycophos (Sodium Glycerophosphate)

Management of hypophosphatemia via Glycophos Management of severe sepsis/septic shock via fluid therapy, antibiotics, vasopressors and inotropics.

DRUG

Antibiotics

Management of severe sepsis/septic shock via fluid therapy, antibiotics, vasopressors and inotropics.

DRUG

Inotropes

Management of severe sepsis/septic shock via fluid therapy, antibiotics, vasopressors and inotropics.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Ahmed Kamal, Dr. · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2020-12-15
Completion
2020-12-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04519762 on ClinicalTrials.gov